Scarica l'app Stockscreener
5.345
1.93%
-0.105
Dopo l'orario di chiusura:
5.20
-0.145
-2.71%
Glucotrack Inc Borsa (GCTK) Ultime notizie
Why GlucoTrack Inc. stock attracts strong analyst attentionFree Smart Investment Opportunities - Newser
How GlucoTrack Inc. stock performs during market volatilityFree Stock Market Analysis Courses - Newser
GlucoTrack (NASDAQ:GCTK) Stock Price Down 1.2% – Here’s What Happened - Defense World
What makes GlucoTrack Inc. stock price move sharplyFree Access to Investment Community - Newser
Implantable glucose monitor competitor emerges with early data - MedTech Dive
GlucoTrack Completes Major Warrant Repurchase - TipRanks
Glucotrack, Inc. Successfully Repurchases Over 90% of Series A Warrants as Part of Capital Formation Strategy - Nasdaq
Glucotrack Announces Repurchase of Series A Warrants - Yahoo Finance
U.S. Stock Movers Today: ULY, NNNN, QS, GCTK, RITR - Markets.com
GlucoTrack Innovation’s Surprise Move: What’s Next? - timothysykes.com
GlucoTrack Inc (NASDAQ: GCTK) – An Analysis Is What You Need - Stocksregister
GlucoTrack (NASDAQ:GCTK) Shares Up 2.6% – What’s Next? - Defense World
Why Did GlucoTrack Plunge 10.71% After Reverse Stock Split? - AInvest
Glucotrack announces 1:60 reverse stock split - Investing.com
GlucoTrack Implements Reverse Stock Split - TipRanks
Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements - mx.advfn.com
Glucotrack announces 1-for-60 reverse stock split effective June 16 By Investing.com - Investing.com South Africa
Glucotrack announces 1-for-60 reverse stock split effective June 16 - Investing.com Nigeria
GlucoTrack Announces 1-for-60 Reverse Stock Split - TipRanks
Glucotrack Implements Major 1-for-60 Reverse Split: What This Means for Your Investment - Stock Titan
Glucotrack’s Innovative Approach to Diabetes Management Sets New Standards - citybuzz -
Rebuilding Trust: How Glucotrack Is Establishing A New Standard In Diabetes Management - Nasdaq
Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions - mx.advfn.com
GlucoTrack to Present at ADA Scientific Sessions - TipRanks
Revolutionary Diabetes Tech: Glucotrack's 3-Year Implantable Monitor Eliminates Daily Finger Pricks - Stock Titan
Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions - The Manila Times
GCTK stock plunges to 52-week low, hits $0.13 By Investing.com - Investing.com South Africa
GCTK stock plunges to 52-week low, hits $0.13 - Investing.com India
Upcoming Benzinga Webinar With Glucotrack To Discuss The Potential Of Its Innovative CBGM Technology To Transform Diabetes Care And Patient Lives - The Globe and Mail
Glucotrack appoints new board member with diabetes tech expertise By Investing.com - Investing.com South Africa
Glucotrack appoints new board member with diabetes tech expertise - Investing.com
Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD - The Manila Times
GlucoTrack (NASDAQ:GCTK) Trading Down 0.2% – Time to Sell? - Defense World
GlucoTrack Approves Key Proposals at Annual Meeting - TipRanks
GCTK stock plunges to 52-week low, touches $0.13 - Investing.com Australia
GCTK stock plunges to 52-week low, touches $0.13 By Investing.com - Investing.com Nigeria
GlucoTrack Establishes Patient Advisory Board for CBGM - TipRanks
Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development - The Manila Times
Glucotrack, Inc. Forms Patient Advisory Board to Enhance Development of Continuous Blood Glucose Monitor - Nasdaq
Groundbreaking 3-Year Implantable Glucose Monitor Gets Patient-Led Development at Glucotrack - Stock Titan
Glucotrack Reports Q1 2025 Financial Results and Progress - TipRanks
Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - The Manila Times
Innovative Continuous Blood Glucose Monitor Shows Promise in First Human Trial - citybuzz -
0.88%
0.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):